Cymbio Pharma Private Limited - Company Profile

It is a healthcare private limited company based in Bangalore, Karnataka, India, established in 1998.
1998 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Cymbio Pharma Private Limited

Cymbio Pharma Private Limited, a active private limited company, was established on 14 September 1998 in Bangalore, Karnataka, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U85110KA1998PTC024210. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹2.50 Cr.

It upholds a compliant status. Employing 34 professional, Its leadership includes Sudarshan Karle (Director), Mahendra Karle (Director), Fiona Karle (Director). Past directors included Amrita Ajith. It holds ₹30.29 Cr open charges and ₹4.10 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at No.23/4, Venkatala Yelahanka Hobli Yelahanka, Bangalore, Karnataka, 560064.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110KA1998PTC024210

  • Registration Number

    024210

  • Incorporation Date

    14 September 1998

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹2.50 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 2.50 Cr
  • Company Age 27 Year, 5 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 30.29 Cr
  • Satisfied Charges ₹ 4.10 Cr
  • Revenue Growth **** 30.58%
  • Profit Growth **** 530.06%
  • Ebitda **** -135.29%
  • Net Worth 25.76%
  • Total Assets **** 13.02%
Company report

Cymbio Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cymbio Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cymbio Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sudarshan Karle Director 24 May 2003 Current
Mahendra Karle Director 24 May 2003 Current
Fiona Karle Director 24 May 2004 Current
Kyung Seon Cho Director 24 May 2004 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 May 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cymbio Pharma.

Cymbio Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 30.58% increase. The company also saw a substantial improvement in profitability, with a 530.06% increase in profit. The company's net worth Soared by an impressive increase of 25.76%.

Cymbio Pharma revenue growth over time
Cymbio Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 30.58%
*******
*******
*******
*******
Revenue from Operations
*******
 29.63%
*******
*******
*******
*******
Total Assets
*******
 13.02%
*******
*******
*******
*******
Profit or Loss
*******
 530.06%
*******
*******
*******
*******
Net Worth
*******
 25.76%
*******
*******
*******
*******
EBITDA
*******
 -135.29%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cymbio Pharma?

In 2023, Cymbio Pharma had a public holding of 4.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹302,900,000.00

Satisfied Charges

₹41,000,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 20.00 Cr
  • Others : 10.29 Cr
Latest Charge Details
Date Lender Amount Status
04 Feb 2025 State Bank Of India ₹20.00 Cr Open
31 Mar 2021 Others ₹3.50 M Open
26 Jun 2014 Others ₹9.94 Cr Open
22 Apr 1999 State Bank Of India ₹2.05 Cr Satisfied
22 Apr 1999 State Bank Of India ₹2.05 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Cymbio Pharma?

Cymbio Pharma has a workforce of 34 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cymbio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cymbio Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cymbio Pharma
Recent Activity within the Organization
  • Charges

    A charge with State Bank Of India amounted to Rs. 20.00 Cr with Charge ID 101051171 was registered on 04 Feb 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 9.94 Cr registered on 26 Jun 2014 with Charge ID 10509146 was modified on 31 Jul 2024. was documented.

  • Annual General Meeting

    Cymbio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Cymbio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was completed.

  • Charges

    A charge with Others amounted to Rs. 0.35 Cr with Charge ID 100436699 was registered on 31 Mar 2021. was recorded as a recent event.

  • Charges

    The activity A charge registered on 22 Apr 1999 via Charge ID 90200372 with State Bank Of India was fully satisfied on 04 Jul 2019. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cymbio Pharma Private Limited?

The CIN of Cymbio Pharma Private Limited is U85110KA1998PTC024210.

Where is Cymbio Pharma Private Limited headquartered?

Cymbio Pharma Private Limited is headquartered at No.23/4, Venkatala Yelahanka Hobli Yelahanka, Bangalore, Karnataka, 560064.

When was Cymbio Pharma Private Limited incorporated?

Cymbio Pharma Private Limited was incorporated on 14 September 1998.

Who are the current directors of Cymbio Pharma Private Limited?

The current directors of Cymbio Pharma Private Limited are

What is the primary industry of Cymbio Pharma Private Limited?

The primary industry of Cymbio Pharma Private Limited is Manufacturing.

Is Cymbio Pharma Private Limited a listed company?

Cymbio Pharma Private Limited is unlisted.

What is the capital structure of Cymbio Pharma Private Limited?

The authorized capital of Cymbio Pharma Private Limited is ₹10.00 Cr, and the paid-up capital is ₹2.50 Cr.

What is the compliance status of Cymbio Pharma Private Limited?

The compliance status of Cymbio Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available